KeyBanc lowered the firm’s price target on FMC (FMC) to $49 from $51 and keeps an Overweight rating on the shares. The firm thinks updates on observed effect of the tariffs on demand in April/May would be consequential for chemical names during Q1 earnings season, while Q1 results and 2025 guidance are now a bit less relevant. Other new major topics KeyBanc expects to be discussed are exposure to U.S. imports of raw materials from high-tariff countries and any outlook on pricing actions to offset higher costs. Further, the firm also expects most companies to see early signs of slower demand, with several data points indicating weak trends in March likely only softened in April.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC:
- FMC receives first product registration in Brazil for Sofero Fall pheromone
- KeyBanc sees Dow Inc., LyondellBasell earnings most at risk after tariff news
- FMC, Bayer collaborate to bring Isoflex to European markets
- FMC’s Financial Outlook: Hold Rating Amid Modest Earnings Adjustments and Market Conditions
- FMC’s Growth Potential: Buy Rating Backed by Market Stability and Strategic Expansion